Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

NCT05718349 is registered in ClinicalTrials.gov with Nicole Hildebrand as lead sponsor.

NCT NCT05718349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05718349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FGF19 in Obstructive Cholestasis: "Unveil the Signal"
Lead sponsor
Nicole Hildebrand
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
June 1, 2025
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, cholestasis, icterus, liver metastasis colon cancer, pancreatic neoplasms